An oral, inactivated vaccine against enterotoxigenic E. coli diarrhoea (ETEC) has been found safe for infants and children in a clinical trial conducted in Bangladesh.
ETEC bacteria are a primary cause of diarrhoea.
They lead to substantial illness and death in children in low- and middle-income countries (LMICs).
The vaccine was developed by Sweden’s University of Gothenburg.